审查对抗卡巴胺抗 Enterobacterales 的新疗法选择
Natalie A Mackow1, David van Duin1
1Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Expert review of anti-infective therapy
|January 6, 2024
概括
对抗卡巴胺耐药肠道细菌 (CRE) 有新的治疗方法,但对金属β-乳糖酶生产者的选择有限. 新的抗生素正在试验中,需要进一步的研究才能获得最佳的CRE治疗.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐卡巴胺肠道细菌 (CRE) 构成了全球严重的健康威胁,医院发作的感染数量不断增加.
- 随着COVID-19的流行,CRE感染的挑战更加严重.
- 虽然新型抗微生物药物正在出现,但对CRE的有效治疗仍然存在关键需求,特别是那些产生金属β-乳酸酶的药物.
研究的目的:
- 审查目前和新兴的CRE感染的抗微生物疗法.
- 要突出治疗产生CRE的金属β-乳糖酶的局限性.
- 强调需要持续的研究和抗微生物药物管理.
主要方法:
- 在PubMed.com进行了全面的文献搜索.
- 搜索术语包括"CRE"",耐卡巴胺肠道细菌"以及特定的药物和耐药机制名称.
- 分析了相关的发表论文和会议摘要.
主要成果:
- 新型抗微生物药物,包括β-lactam-β-lactamase抑制剂组合,现在可用于CRE.
- 对于产生CRE的金属β-乳糖酶的治疗选择仍然有限.
- 几种有前途的新化合物正在进行临床试验.
结论:
- 现有的新型抗微生物药物显示出希望,但对于产生CRE的金属β-乳糖酶,仍然存在差距.
- 进一步开发针对这些耐药菌株的抗生素至关重要.
- 优化临床研究和抗菌药物管理对于打击CRE传播和耐药性至关重要.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.7K
12:58A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.0K
相关概念视频
00:57Antibiotic Selection
53.8K
Overview
53.8K
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
410
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
410